Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Endostatins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Nasopharyngeal Carcinoma 7 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Solid Tumors 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1 Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 25 fludarabine 16 romidepsin 14 Brentuximab Vedotin 13 Etoposide 12 Vincristine 11 Doxorubicin 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Gemcitabine 10 fludarabine phosphate 9 Prednisone 9 Biopsy 9 10-propargyl-10-deazaaminopterin 9 pembrolizumab 8 Whole-Body Irradiation 8 Specimen Handling 8 Rituximab 8 Lenalidomide 8 Busulfan 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Depsipeptides 6 Cytarabine 6 duvelisib 5 Vorinostat 5 Carmustine 5 Bortezomib 5 Bendamustine Hydrochloride 5 Azacitidine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡